Cargando…
MTA1 as negative prognostic marker in vulvar carcinoma
PURPOSE: Vulvar cancer is the fourth most common malignancy of the female genital tract after endometrial, ovarian, and cervical carcinoma and affects mainly elderly women. In 2020 there were registered more than 17,000 deaths worldwide related to vulvar carcinoma. Data about target-based therapies...
Autores principales: | Wanka, Giulia, Jueckstock, Julia, Wild, Carl Mathis, Vattai, Aurelia, Fürst, Sophie, Heidegger, Helene H., Kuhn, Christina, Schmoeckel, Elisa, Jeschke, Udo, Dannecker, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356867/ https://www.ncbi.nlm.nih.gov/pubmed/36689059 http://dx.doi.org/10.1007/s00432-023-04579-4 |
Ejemplares similares
-
LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients
por: Wanka, Giulia, et al.
Publicado: (2020) -
EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer
por: Buchholz, Anna, et al.
Publicado: (2021) -
Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022) -
Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2022) -
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2021)